Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1386-1392

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torzewski, J.
Right arrow Articles by Hombach, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torzewski, J.
Right arrow Articles by Hombach, V.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1386-1392.)
© 1998 American Heart Association, Inc.


Original Contributions

C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries

Jan Torzewski; Michael Torzewski; David E. Bowyer; Margit Fröhlich; Wolfgang Koenig; Johannes Waltenberger; Colin Fitzsimmons; ; Vinzenz Hombach

From the Department of Cardiology, University of Ulm, Ulm, Germany (J.T., M.F., W.K., J.W., V.H.); the Department of Pathology, Heinrich-Heine-University Düsseldorf, Germany (M.T.); and the Department of Pathology, University of Cambridge, Cambridge, UK (D.E.B., C.F.).

Correspondence to Dr Michael Torzewski, Department of Pathology, Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany. E-mail torzewsk{at}mail-rz.uni-duesseldorf.de

Abstract—There is increasing evidence that complement activation may play a role in atherogenesis. Complement proteins have been demonstrated to be present in early atherosclerotic lesions of animals and humans, and cholesterol-induced atherosclerotic lesion formation is reduced in complement-deficient animals. Potential complement activators in atherosclerotic lesions are now a subject matter of debate. C-reactive protein (CRP) is an acute-phase protein that is involved in inflammatory processes in numerous ways. It binds to lipoproteins and activates the complement system via the classic pathway. In this study we have investigated early atherosclerotic lesions of human coronary arteries by means of immunohistochemical staining. We demonstrate here that CRP deposits in the arterial wall in early atherosclerotic lesions with 2 predominant manifestations. First, there is a diffuse rather than a focal deposition in the deep fibroelastic layer and in the fibromuscular layer of the intima adjacent to the media. In this location, CRP frequently colocalizes with the terminal complement complex. Second, the majority of foam cells below the endothelium show positive staining for CRP. In this location, no colocalization with the terminal complement proteins can be observed. Our data suggest that CRP may promote atherosclerotic lesion formation by activating the complement system and being involved in foam cell formation.


Key Words: atherogenesis • C-reactive protein • complement • inflammation




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. R. Kinderlerer, F. Ali, M. Johns, E. A. Lidington, V. Leung, J. J. Boyle, S. S. Hamdulay, P. C. Evans, D. O. Haskard, and J. C. Mason
KLF2-dependent, Shear Stress-induced Expression of CD59: A NOVEL CYTOPROTECTIVE MECHANISM AGAINST COMPLEMENT-MEDIATED INJURY IN THE VASCULATURE
J. Biol. Chem., May 23, 2008; 283(21): 14636 - 14644.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. B. Grammer, W. Marz, W. Renner, B. O. Bohm, and M. M. Hoffmann
C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study
Eur. Heart J., May 21, 2008; (2008) ehn191v1.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. A. Van Vre, H. Bult, V. Y. Hoymans, V. F.I. Van Tendeloo, C. J. Vrints, and J. M. Bosmans
Human C-Reactive Protein Activates Monocyte-Derived Dendritic Cells and Induces Dendritic Cell-Mediated T-Cell Activation
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 511 - 518.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Marsik, L. Kazemi-Shirazi, T. Schickbauer, S. Winkler, C. Joukhadar, O. F. Wagner, and G. Endler
C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Clin. Chem., February 1, 2008; 54(2): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. Vidula, L. Tian, K. Liu, M. H. Criqui, L. Ferrucci, W. H. Pearce, P. Greenland, D. Green, J. Tan, D. B. Garside, et al.
Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study
Ann Intern Med, January 15, 2008; 148(2): 85 - 93.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Yamaleyeva, K. D. Pendergrass, N. T. Pirro, P. E. Gallagher, L. Groban, and M. C. Chappell
Ovariectomy is protective against renal injury in the high-salt-fed older mRen2.Lewis rat
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2064 - H2071.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. N. Patel, C. A. King, S. R. Bailey, J. W. Holt, K. Venkatachalam, A. Agrawal, A. J. Valente, and B. Chandrasekar
Interleukin-17 Stimulates C-reactive Protein Expression in Hepatocytes and Smooth Muscle Cells via p38 MAPK and ERK1/2-dependent NF-{kappa}B and C/EBPbeta Activation
J. Biol. Chem., September 14, 2007; 282(37): 27229 - 27238.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
I. Barutcu, A. T. Sezgin, N. Sezgin, H. Gullu, A. M. Esen, E. Topal, R. Ozdemir, F. Kosar, and S. Cehreli
Increased High Sensitive CRP Level and Its Significance in Pathogenesis of Slow Coronary Flow
Angiology, September 1, 2007; 58(4): 401 - 407.
[Abstract] [PDF]


Home page
Eur Heart JHome page
J. K. Pai, J. E. Manson, K. M. Rexrode, C. M. Albert, D. J. Hunter, and E. B. Rimm
Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women
Eur. Heart J., June 1, 2007; 28(11): 1297 - 1303.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. M. Ridker
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus
J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2129 - 2138.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S. Norja, L. Nuutila, P. J Karhunen, and S. Goebeler
C-reactive protein in vulnerable coronary plaques
J. Clin. Pathol., May 1, 2007; 60(5): 545 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Rocker, D. E. Manolov, E. V. Kuzmenkina, K. Tron, H. Slatosch, J. Torzewski, and G. U. Nienhaus
Affinity of C-Reactive Protein toward Fc{gamma}RI Is Strongly Enhanced by the {gamma}-Chain
Am. J. Pathol., February 1, 2007; 170(2): 755 - 763.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M McMahon, J Grossman, W Chen, and B H Hahn
Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
Lupus, November 1, 2006; 15(11_suppl): 59 - 69.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. D. Kolodgie, A. P. Burke, K. S. Skorija, E. Ladich, R. Kutys, A. T. Makuria, and R. Virmani
Lipoprotein-Associated Phospholipase A2 Protein Expression in the Natural Progression of Human Coronary Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2523 - 2529.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Libby and P. M. Ridker
Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A33 - A46.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. A. Wilkinson, J. A. Bilello, G. W. Hagan, R. S. Vessey, and J. A. Wedzicha
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 867 - 874.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Somani, P. J. Grant, K. Kain, A. J. Catto, and A. M. Carter
Complement C3 and C-Reactive Protein Are Elevated in South Asians Independent of a Family History of Stroke
Stroke, August 1, 2006; 37(8): 2001 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Paffen and M. P.M. deMaat
C-reactive protein in atherosclerosis: A causal factor?
Cardiovasc Res, July 1, 2006; 71(1): 30 - 39.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Hemelaar, P. Kenemans, C.G. Schalkwijk, D.D.M. Braat, and M.J. van der Mooren
No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women
Hum. Reprod., June 1, 2006; 21(6): 1635 - 1642.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, I. Jialal, B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, and I. Jialal
The Verdict Is Still Out
Circulation, May 2, 2006; 113(17): 2128 - 2151.
[Full Text] [PDF]


Home page
StrokeHome page
J. Krupinski, M. M. Turu, J. Martinez-Gonzalez, A. Carvajal, J. O. Juan-Babot, E. Iborra, M. Slevin, F. Rubio, and L. Badimon
Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques
Stroke, May 1, 2006; 37(5): 1200 - 1204.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Montero, J. Orbe, N. Varo, O. Beloqui, J. I. Monreal, J. A. Rodriguez, J. Diez, P. Libby, and J. A. Paramo
C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells: Implications for Clinical and Subclinical Atherosclerosis
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S.-R. Ji, Y. Wu, L. A. Potempa, Y.-H. Liang, and J. Zhao
Effect of Modified C-Reactive Protein on Complement Activation: A Possible Complement Regulatory Role of Modified or Monomeric C-Reactive Protein in Atherosclerotic Lesions
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine
Inflammatory Biomarkers in Acute Coronary Syndromes: Part II: Acute-Phase Reactants and Biomarkers of Endothelial Cell Activation
Circulation, February 21, 2006; 113(7): e152 - e155.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Meuwissen, A C van der Wal, H W M Niessen, K T Koch, R J de Winter, C M van der Loos, S Z H Rittersma, S A J Chamuleau, J G P Tijssen, A E Becker, et al.
Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction
J. Clin. Pathol., February 1, 2006; 59(2): 196 - 201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Torzewski
C-Reactive Protein and Atherogenesis: New Insights from Established Animal Models
Am. J. Pathol., October 1, 2005; 167(4): 923 - 925.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Sun, T. Koike, T. Ichikawa, K. Hatakeyama, M. Shiomi, B. Zhang, S. Kitajima, M. Morimoto, T. Watanabe, Y. Asada, et al.
C-Reactive Protein in Atherosclerotic Lesions: Its Origin and Pathophysiological Significance
Am. J. Pathol., October 1, 2005; 167(4): 1139 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Reifenberg, H.-A. Lehr, D. Baskal, E. Wiese, S. C. Schaefer, S. Black, D. Samols, M. Torzewski, K. J. Lackner, M. Husmann, et al.
Role of C-Reactive Protein in Atherogenesis: Can the Apolipoprotein E Knockout Mouse Provide the Answer?
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1641 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Inoue, T. Kato, T. Uchida, M. Sakuma, A. Nakajima, M. Shibazaki, Y. Imoto, M. Saito, S. Hashimoto, Y. Hikichi, et al.
Local Release of C-Reactive Protein From Vulnerable Plaque or Coronary Arterial Wall Injured by Stenting
J. Am. Coll. Cardiol., July 19, 2005; 46(2): 239 - 245.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. M. Hirschfield, J. R. Gallimore, M. C. Kahan, W. L. Hutchinson, C. A. Sabin, G. M. Benson, A. P. Dhillon, G. A. Tennent, and M. B. Pepys
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
PNAS, June 7, 2005; 102(23): 8309 - 8314.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. E. Taylor, J. C. Giddings, and C. W. van den Berg
C-Reactive Protein-Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1225 - 1230.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. van Tits, J. de Graaf, H. Toenhake, W. van Heerde, and A. Stalenhoef
C-Reactive Protein and Annexin A5 Bind to Distinct Sites of Negatively Charged Phospholipids Present in Oxidized Low-Density Lipoprotein
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. R. Clapp, G. M. Hirschfield, C. Storry, J. R. Gallimore, R. P. Stidwill, M. Singer, J. E. Deanfield, R. J. MacAllister, M. B. Pepys, P. Vallance, et al.
Inflammation and Endothelial Function: Direct Vascular Effects of Human C-Reactive Protein on Nitric Oxide Bioavailability
Circulation, March 29, 2005; 111(12): 1530 - 1536.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Maier, L. A. Altwegg, R. Corti, S. Gay, M. Hersberger, F. E. Maly, G. Sutsch, M. Roffi, M. Neidhart, F. R. Eberli, et al.
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein
Circulation, March 22, 2005; 111(11): 1355 - 1361.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Ivashchenko, F. Kramer, S. Schafer, A. Bucher, K. Veit, V. Hombach, A. Busch, O. Ritzeler, J. Dedio, and J. Torzewski
Protein Kinase C Pathway Is Involved in Transcriptional Regulation of C-Reactive Protein Synthesis in Human Hepatocytes
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 186 - 192.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. E. Manolov, C. Rocker, V. Hombach, G. U. Nienhaus, and J. Torzewski
Ultrasensitive Confocal Fluorescence Microscopy of C-Reactive Protein Interacting With Fc{gamma}RIIa
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2372 - 2377.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Paffen, H. L. Vos, and R. M. Bertina
C-Reactive Protein Does Not Directly Induce Tissue Factor in Human Monocytes
Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 975 - 981.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Bhakdi, M. Torzewski, K. Paprotka, S. Schmitt, H. Barsoom, P. Suriyaphol, S.-R. Han, K. J. Lackner, and M. Husmann
Possible Protective Role for C-Reactive Protein in Atherogenesis: Complement Activation by Modified Lipoproteins Halts Before Detrimental Terminal Sequence
Circulation, April 20, 2004; 109(15): 1870 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. B. Schulze, E. B. Rimm, T. Li, N. Rifai, M. J. Stampfer, and F. B. Hu
C-Reactive Protein and Incident Cardiovascular Events Among Men With Diabetes
Diabetes Care, April 1, 2004; 27(4): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Arroyo-Espliguero, P. Avanzas, J. Cosin-Sales, G. Aldama, C. Pizzi, and J. C. Kaski
C-reactive protein elevation and disease activity in patients with coronary artery disease
Eur. Heart J., March 1, 2004; 25(5): 401 - 408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. T. Lane
Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F442 - F450.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Wakatsuki, N. Ikenoue, K. Shinohara, K. Watanabe, and T. Fukaya
Effect of Lower Dosage of Oral Conjugated Equine Estrogen on Inflammatory Markers and Endothelial Function in Healthy Postmenopausal Women
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 571 - 576.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Paul, K. W.S. Ko, L. Li, V. Yechoor, M. A. McCrory, A. J. Szalai, and L. Chan
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation, February 10, 2004; 109(5): 647 - 655.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. L. Stauffer, G. L. Hoetzer, D. T. Smith, and C. A. DeSouza
Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy
J Appl Physiol, January 1, 2004; 96(1): 143 - 148.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. N. Williams, C. X. Zhang, B. A. Game, L. He, and Y. Huang
C-Reactive Protein Stimulates MMP-1 Expression in U937 Histiocytes Through Fc{gamma}RII and Extracellular Signal-Regulated Kinase Pathway:: An Implication of CRP Involvement in Plaque Destabilization
Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
G.M. Hirschfield and M.B. Pepys
C-reactive protein and cardiovascular disease: new insights from an old molecule
QJM, November 1, 2003; 96(11): 793 - 807.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. J. Blake and P. M. Ridker
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1250 - R1252.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D.J. Brull, N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D.O. Lowe, M.J. World, S.E. Humphries, et al.
Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2063 - 2069.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Calabro, J. T. Willerson, and E. T.H. Yeh
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells
Circulation, October 21, 2003; 108(16): 1930 - 1932.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. F. Arenillas, J. Alvarez-Sabin, C. A. Molina, P. Chacon, J. Montaner, A. Rovira, B. Ibarra, and M. Quintana
C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease
Stroke, October 1, 2003; 34(10): 2463 - 2468.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. J. Lindsberg and A. J. Grau
Inflammation and Infections as Risk Factors for Ischemic Stroke
Stroke, October 1, 2003; 34(10): 2518 - 2532.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. P. Miller, Y.-F. Chen, D. Xing, W. Feng, and S. Oparil
Hormone Replacement Therapy and Inflammation: Interactions in Cardiovascular Disease
Hypertension, October 1, 2003; 42(4): 657 - 663.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. J. Jabs, E. Theissing, M. Nitschke, J.F. M. Bechtel, M. Duchrow, S. Mohamed, B. Jahrbeck, H.-H. Sievers, J. Steinhoff, and C. Bartels
Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue
Circulation, September 23, 2003; 108(12): 1428 - 1431.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. G. Hackam and S. S. Anand
Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence
JAMA, August 20, 2003; 290(7): 932 - 940.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Holvoet, T. B. Harris, R. P. Tracy, P. Verhamme, A. B. Newman, S. M. Rubin, E. M. Simonsick, L. H. Colbert, and S. B. Kritchevsky
Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly: Findings From the Health, Aging, and Body Composition Study
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1444 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kobayashi, N. Inoue, Y. Ohashi, M. Terashima, K. Matsui, T. Mori, H. Fujita, K. Awano, K. Kobayashi, H. Azumi, et al.
Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque Instability: Important Role of C-Reactive Protein
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1398 - 1404.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Schillinger, M. Exner, W. Mlekusch, M. Haumer, H. Rumpold, R. Ahmadi, S. Sabeti, O. Wagner, and E. Minar
Endovascular Revascularization Below the Knee: 6-month Results and Predictive Value of C-reactive Protein Level
Radiology, May 1, 2003; 227(2): 419 - 425.
[Abstract] [Full Text] [PDF]